Aromatase inhibitors (AIs), such as anastrozole and letrozole, block aromatase and interfere with conversion of androgens into estrogens, and form the backbone of treatment for ER + ve BC (Supplementary Fig. 1). This evidence concerns the gene ESR1 and breast cancer.